No Data
No Data
Express News | Telomir Pharmaceuticals Inc - to Submit Ind & Inad Application by Q4 2025, With Clinical Trials Planned for 2026
EXCLUSIVE: Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson's Disease
Express News | Telomir Pharmaceuticals Shares Down 12.57% at $4.45 in Premarket Trade; White Diamind Research Says It Has a Strong Sell Rating on the Stock
Express News | Telomir Pharmaceuticals Announced It Raised $1M In Equity Funding Through Starwood Trust
Telomir Pharmaceuticals Enters Into Stock Purchase Agreement
Telomir Pharmaceuticals Raises $1M At $7 Per Share In No-warrant, Restricted Common Stock Deal - Filing